Crona Corp.

Crona Corp. is a U.S.-based service company focused on disinfection and anti-microbial protection under its ZeroBlast process. It sells infection-control treatments that are applied to facilities and vehicles to reduce germs, viruses, and pathogens for up to 90 days per treatment cycle.

— Crona Corp.
%
Disinfection and antimicrobial services80% Hands-on cleaning, disinfection, and anti-microbial protection services for facilities and vehicles.
Testing and assessment10% Pre-treatment contamination testing used to demonstrate infection risk and support service sales.
Recurring retreatment contracts10% Scheduled 90-day follow-up treatments that maintain protection and create repeat service revenue.

Crona sells infection-control services to organizations that need visible hygiene and pathogen-reduction measures in...

  • Healthcare and care facilitiesprimary

    Hospitals, medical clinics, and care homes buy disinfection services to reduce pathogen spread in high-risk environments.

  • Hospitality and food serviceprimary

    Restaurants and hotels use the service to improve sanitation visibility and customer confidence.

  • Education and public facilitiessecondary

    Classrooms and similar shared spaces buy treatments to lower infection risk in dense occupancy settings.

  • Transportation and fleetsecondary

    Emergency vehicles and fleet vehicles are treated to reduce contamination in high-touch enclosed spaces.

  • Commercial and industrial sitessecondary

    Offices and industrial sites purchase protection for workplace hygiene and operational continuity.

  • Residential and sportsemerging

    Homes and professional sports teams use the service for anti-microbial protection and safety assurance.

Crona is headquartered in the United States, but the filings provided do not disclose meaningful revenue by country or...

  • Head office is in Vancouver, British Columbia
  • Country-level revenue disclosure was not provided
  • Business is described as global in customer application, but not quantified
  • U.S. filing and U.S. customer examples indicate North American focus
  • No revenue has been generated yet, so geographic exposure is limited

Management’s immediate priority is to secure financing and continue building the service business while operating as an...

01
Secure external financingshort-term

The company has no cash and needs funding to sustain operations and execute its plan.

02
Commercialize recurring infection-control servicesmedium-term

A repeat-treatment model is needed to create durable revenue and customer retention.

03
Expand operating capacitymedium-term

The company currently has no employees and relies on a sole officer, limiting scale.

Crona faces substantial going-concern and liquidity risk because it has no cash, no revenue, and recurring operating...

critical

Going-concern uncertainty

The company has no cash, negative working capital, and expects continued losses and negative cash flow.

Scope
All operations
Materiality
high
high

Financing and dilution risk

Operations depend on additional equity or debt financing, which may be unavailable or expensive.

Scope
Capital structure
Materiality
high
high

Commercialization risk

The service has not yet generated revenue, so customer adoption and repeat demand are unproven.

Scope
Revenue generation
Materiality
high
medium

Operational concentration risk

The company has no employees and relies on a sole officer/director for execution.

Scope
Management and delivery
Materiality
medium
medium

Regulatory and compliance risk

Disinfection services must comply with government rules in each facility and jurisdiction served.

Scope
Service delivery
Materiality
medium
Going-concern assessment
May require heightened scrutiny of asset recoverability and financing assumptions
Debt forgiveness
Can materially inflate net income without improving core business performance
Related-party financing
Important for understanding sustainability of cash resources
Share-based compensation
Affects operating expense and net loss comparability

: 28.4.2026